Competition in the pharmaceutical industry: the declining profitability of drug innovation
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington u.a.
American Enterprise Inst. for Public Policy Research
1983
|
| Schriftenreihe: | American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies
374. |
| Schlagworte: | |
| Beschreibung: | 84 S. graph. Darst. |
| ISBN: | 0844735140 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV006139920 | ||
| 003 | DE-604 | ||
| 005 | 20151221 | ||
| 007 | t | ||
| 008 | 921030s1983 d||| |||| 00||| eng d | ||
| 020 | |a 0844735140 |9 0-8447-3514-0 | ||
| 035 | |a (OCoLC)9441735 | ||
| 035 | |a (DE-599)BVBBV006139920 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-739 |a DE-N2 |a DE-706 |a DE-188 | ||
| 050 | 0 | |a HD9666.5 | |
| 082 | 0 | |a 338.4/36151/0973 |2 19 | |
| 084 | |a QR 200 |0 (DE-625)142022: |2 rvk | ||
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 100 | 1 | |a Statman, Meir |e Verfasser |0 (DE-588)170002829 |4 aut | |
| 245 | 1 | 0 | |a Competition in the pharmaceutical industry |b the declining profitability of drug innovation |c Meir Statman |
| 264 | 1 | |a Washington u.a. |b American Enterprise Inst. for Public Policy Research |c 1983 | |
| 300 | |a 84 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies |v 374. | |
| 490 | 0 | |a American Enterprise Institute studies in health policy | |
| 650 | 4 | |a Concurrence - États-Unis | |
| 650 | 7 | |a Concurrentie |2 gtt | |
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 4 | |a Industrie pharmaceutique - États-Unis | |
| 650 | 4 | |a Médicaments - Dénomination commune - Aspect économique - États-Unis | |
| 650 | 4 | |a Médicaments - Recherche - États-Unis - Coût | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Competition |z United States | |
| 650 | 4 | |a Drug Industry |x economics |z United States | |
| 650 | 4 | |a Drugs |x Research |z United States |x Costs | |
| 650 | 4 | |a Economic Competition |z United States | |
| 650 | 4 | |a Economics |z United States | |
| 650 | 4 | |a Generic drugs |z United States | |
| 650 | 4 | |a Pharmaceutical industry |z United States | |
| 650 | 4 | |a Technology, Pharmaceutical |x economics |z United States | |
| 650 | 0 | 7 | |a Wettbewerb |0 (DE-588)4065835-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Wettbewerb |0 (DE-588)4065835-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 830 | 0 | |a American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies |v 374. |w (DE-604)BV000001481 |9 374 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003880822 | ||
Datensatz im Suchindex
| _version_ | 1804120365359693824 |
|---|---|
| any_adam_object | |
| author | Statman, Meir |
| author_GND | (DE-588)170002829 |
| author_facet | Statman, Meir |
| author_role | aut |
| author_sort | Statman, Meir |
| author_variant | m s ms |
| building | Verbundindex |
| bvnumber | BV006139920 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9666 |
| callnumber-raw | HD9666.5 |
| callnumber-search | HD9666.5 |
| callnumber-sort | HD 49666.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 200 QR 525 |
| ctrlnum | (OCoLC)9441735 (DE-599)BVBBV006139920 |
| dewey-full | 338.4/36151/0973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/36151/0973 |
| dewey-search | 338.4/36151/0973 |
| dewey-sort | 3338.4 536151 3973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02376nam a2200589 cb4500</leader><controlfield tag="001">BV006139920</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151221 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921030s1983 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844735140</subfield><subfield code="9">0-8447-3514-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)9441735</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006139920</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-N2</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9666.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/36151/0973</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 200</subfield><subfield code="0">(DE-625)142022:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Statman, Meir</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)170002829</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Competition in the pharmaceutical industry</subfield><subfield code="b">the declining profitability of drug innovation</subfield><subfield code="c">Meir Statman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington u.a.</subfield><subfield code="b">American Enterprise Inst. for Public Policy Research</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">84 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies</subfield><subfield code="v">374.</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">American Enterprise Institute studies in health policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Concurrence - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Concurrentie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Dénomination commune - Aspect économique - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche - États-Unis - Coût</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Competition</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="x">Costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economic Competition</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Generic drugs</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wettbewerb</subfield><subfield code="0">(DE-588)4065835-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wettbewerb</subfield><subfield code="0">(DE-588)4065835-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies</subfield><subfield code="v">374.</subfield><subfield code="w">(DE-604)BV000001481</subfield><subfield code="9">374</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003880822</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV006139920 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:40:56Z |
| institution | BVB |
| isbn | 0844735140 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003880822 |
| oclc_num | 9441735 |
| open_access_boolean | |
| owner | DE-703 DE-739 DE-N2 DE-706 DE-188 |
| owner_facet | DE-703 DE-739 DE-N2 DE-706 DE-188 |
| physical | 84 S. graph. Darst. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | American Enterprise Inst. for Public Policy Research |
| record_format | marc |
| series | American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies |
| series2 | American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies American Enterprise Institute studies in health policy |
| spelling | Statman, Meir Verfasser (DE-588)170002829 aut Competition in the pharmaceutical industry the declining profitability of drug innovation Meir Statman Washington u.a. American Enterprise Inst. for Public Policy Research 1983 84 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies 374. American Enterprise Institute studies in health policy Concurrence - États-Unis Concurrentie gtt Farmaceutische industrie gtt Industrie pharmaceutique - États-Unis Médicaments - Dénomination commune - Aspect économique - États-Unis Médicaments - Recherche - États-Unis - Coût Wirtschaft Competition United States Drug Industry economics United States Drugs Research United States Costs Economic Competition United States Economics United States Generic drugs United States Pharmaceutical industry United States Technology, Pharmaceutical economics United States Wettbewerb (DE-588)4065835-1 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf USA Pharmazeutische Industrie (DE-588)4045696-1 s Wettbewerb (DE-588)4065835-1 s DE-604 American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies 374. (DE-604)BV000001481 374 |
| spellingShingle | Statman, Meir Competition in the pharmaceutical industry the declining profitability of drug innovation American Enterprise Institute for Public Policy Research <Washington, DC>: AEI studies Concurrence - États-Unis Concurrentie gtt Farmaceutische industrie gtt Industrie pharmaceutique - États-Unis Médicaments - Dénomination commune - Aspect économique - États-Unis Médicaments - Recherche - États-Unis - Coût Wirtschaft Competition United States Drug Industry economics United States Drugs Research United States Costs Economic Competition United States Economics United States Generic drugs United States Pharmaceutical industry United States Technology, Pharmaceutical economics United States Wettbewerb (DE-588)4065835-1 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| subject_GND | (DE-588)4065835-1 (DE-588)4045696-1 |
| title | Competition in the pharmaceutical industry the declining profitability of drug innovation |
| title_auth | Competition in the pharmaceutical industry the declining profitability of drug innovation |
| title_exact_search | Competition in the pharmaceutical industry the declining profitability of drug innovation |
| title_full | Competition in the pharmaceutical industry the declining profitability of drug innovation Meir Statman |
| title_fullStr | Competition in the pharmaceutical industry the declining profitability of drug innovation Meir Statman |
| title_full_unstemmed | Competition in the pharmaceutical industry the declining profitability of drug innovation Meir Statman |
| title_short | Competition in the pharmaceutical industry |
| title_sort | competition in the pharmaceutical industry the declining profitability of drug innovation |
| title_sub | the declining profitability of drug innovation |
| topic | Concurrence - États-Unis Concurrentie gtt Farmaceutische industrie gtt Industrie pharmaceutique - États-Unis Médicaments - Dénomination commune - Aspect économique - États-Unis Médicaments - Recherche - États-Unis - Coût Wirtschaft Competition United States Drug Industry economics United States Drugs Research United States Costs Economic Competition United States Economics United States Generic drugs United States Pharmaceutical industry United States Technology, Pharmaceutical economics United States Wettbewerb (DE-588)4065835-1 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| topic_facet | Concurrence - États-Unis Concurrentie Farmaceutische industrie Industrie pharmaceutique - États-Unis Médicaments - Dénomination commune - Aspect économique - États-Unis Médicaments - Recherche - États-Unis - Coût Wirtschaft Competition United States Drug Industry economics United States Drugs Research United States Costs Economic Competition United States Economics United States Generic drugs United States Pharmaceutical industry United States Technology, Pharmaceutical economics United States Wettbewerb Pharmazeutische Industrie USA |
| volume_link | (DE-604)BV000001481 |
| work_keys_str_mv | AT statmanmeir competitioninthepharmaceuticalindustrythedecliningprofitabilityofdruginnovation |